137 related articles for article (PubMed ID: 17367815)
21. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
22. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
[TBL] [Abstract][Full Text] [Related]
23. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.
Nakamura K; Igarashi K; Ide K; Ohkawa R; Okubo S; Yokota H; Masuda A; Oshima N; Takeuchi T; Nangaku M; Okudaira S; Arai H; Ikeda H; Aoki J; Yatomi Y
Clin Chim Acta; 2008 Feb; 388(1-2):51-8. PubMed ID: 17963703
[TBL] [Abstract][Full Text] [Related]
24. [Laboratory-Based Clinical Research I am Aiming for].
Yatomi Y
Rinsho Byori; 2014 Nov; 62(11):1052-5. PubMed ID: 27509720
[TBL] [Abstract][Full Text] [Related]
25. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
Billon-Denis E; Tanfin Z; Robin P
J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid.
Liu XW; Sok DE; Yook HS; Sohn CB; Chung YJ; Kim MR
J Agric Food Chem; 2007 Oct; 55(21):8717-22. PubMed ID: 17887800
[TBL] [Abstract][Full Text] [Related]
27. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
[TBL] [Abstract][Full Text] [Related]
28. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids.
Tokumura A
Biochim Biophys Acta; 2002 May; 1582(1-3):18-25. PubMed ID: 12069806
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid production from lysophosphatidylcholine by lysophospholipase D activity of autotaxin in plasma of women with normal and adverse pregnancies.
Tsutsumi T; Yasuda K; Neya M; Okada H; Tokumura A
Prostaglandins Other Lipid Mediat; 2022 Dec; 163():106670. PubMed ID: 35963509
[TBL] [Abstract][Full Text] [Related]
30. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
[TBL] [Abstract][Full Text] [Related]
31. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.
Mazereeuw-Hautier J; Gres S; Fanguin M; Cariven C; Fauvel J; Perret B; Chap H; Salles JP; Saulnier-Blache JS
J Invest Dermatol; 2005 Sep; 125(3):421-7. PubMed ID: 16117781
[TBL] [Abstract][Full Text] [Related]
32. Serum autotaxin is not a useful biomarker for ovarian cancer.
Nakamura K; Igarashi K; Ohkawa R; Yokota H; Masuda A; Nakagawa S; Yano T; Ikeda H; Aoki J; Yatomi Y
Lipids; 2012 Sep; 47(9):927-30. PubMed ID: 22700442
[TBL] [Abstract][Full Text] [Related]
33. Mediators of pruritus during cholestasis.
Oude Elferink RP; Kremer AE; Beuers U
Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
[TBL] [Abstract][Full Text] [Related]
34. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
[TBL] [Abstract][Full Text] [Related]
35. Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis.
Tsuboi K; Okamoto Y; Rahman IA; Uyama T; Inoue T; Tokumura A; Ueda N
Biochim Biophys Acta; 2015 May; 1851(5):537-48. PubMed ID: 25596343
[TBL] [Abstract][Full Text] [Related]
36. Lysophospholipids and lysophospholipase D in rabbit aqueous humor following corneal injury.
Tokumura A; Taira S; Kikuchi M; Tsutsumi T; Shimizu Y; Watsky MA
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):83-9. PubMed ID: 22281604
[TBL] [Abstract][Full Text] [Related]
37. The heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activity.
Aoyama C; Sugimoto H; Ando H; Yamashita S; Horibata Y; Sugimoto S; Satou M
Biochem J; 2011 Dec; 440(2):241-50. PubMed ID: 21812758
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
Xu Y; Shen Z; Wiper DW; Wu M; Morton RE; Elson P; Kennedy AW; Belinson J; Markman M; Casey G
JAMA; 1998 Aug; 280(8):719-23. PubMed ID: 9728644
[TBL] [Abstract][Full Text] [Related]
39. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy.
Tokumura A; Kanaya Y; Miyake M; Yamano S; Irahara M; Fukuzawa K
Biol Reprod; 2002 Nov; 67(5):1386-92. PubMed ID: 12390867
[TBL] [Abstract][Full Text] [Related]
40. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.
Block RC; Duff R; Lawrence P; Kakinami L; Brenna JT; Shearer GC; Meednu N; Mousa S; Friedman A; Harris WS; Larson M; Georas S
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):87-95. PubMed ID: 20106646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
